1 / 9

Global Diabetic Retinopathy Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 a

Diabetic retinopathy is the most common form of diabetic eye disease. Diabetic retinopathy usually affects the people with diabetes from number of years. High glucose levels in the cause damage to the retinal blood vessels is the main manifestation in diabetic retinopathy. In some other cases, the retinal blood vessels will be swollen (macular oedema) with a fluid leaking into rear of eye. In few cases, on the surface of the retinal blood vessels will grow abnormally. If diabetic retinopathy is not properly treated, can progressively become more serious and seriously affects vision which may leads to blindness.

saikrishna
Download Presentation

Global Diabetic Retinopathy Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 a

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Diabetic Retinopathy Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017- 2023 ©2017 Precision BusinessInsights

  2. Diabetic retinopathy is the most common form of diabetic eye disease. Diabetic retinopathy usually affects the people with diabetes from number of years. High glucose levels in the cause damage to the retinal blood vessels is the main manifestation in diabetic retinopathy. In some other cases, the retinal blood vessels will be swollen (macular oedema) with a fluid leaking into rear of eye. In few cases, on the surface of the retinal blood vessels will grow abnormally. If diabetic retinopathy is not properly treated, can progressively become more serious and seriously affects vision which may leads to blindness. Diabetic Retinopathy will affect both type 1 and type 2 diabetic patients and due to the abundant increase in the pool of patients with Diabetes, According to the World Health Organisation (WHO), 41 % of global population with diabetes are geriatric patients which is highly attributing the growth of the diabetic retinopathy market. Furthermore, rise in healthcare infrastructure up-gradation, rise in demand for the early diagnosis devices are the few factors having significant impact in driving the diabetic retinopathy market. However, paucity of skilled ophthalmologist, lack of primary infrastructure and insurance facilities are some of the restraining factors that are hampering the growth of diabetic retinopathy market. A sample of this report is available upon request @ https://www.precisionbusinessinsights.com/market-reports/global-diabetic-retinopathy-market/#ulp-4H8Z4LpNMLEuOnnx ©2017 Precision BusinessInsights

  3. The global diabetic retinopathy treatment market is segmented on the basis of treatment, end users, type, and geographical regions. Based on the type, global diabetic retinopathy treatment market is segmented as: Proliferative Diabetic Retinopathy Diabetic Molecular Edema Based on the drug class, the global diabetic retinopathy treatment market is segmented as: Corticosteroids Anti-VEGF (vascular endothelial growth factor) Based on the basis distribution channels, the global Diabetic retinopathy Treatment Market is segmented as: Ophthalmic Clinics Hospital Pharmacies Retail pharmacies To view TOC of this report is available upon request @ https://www.precisionbusinessinsights.com/market-reports/global-diabetic-retinopathy-market/#ulp-c654SbFYO64MsOhu ©2017 Precision BusinessInsights

  4. Diabetic retinopathy can be treated by various methods depending on the stage of disease. Diabetic retinopathy is one of the major causes of blindness in adult population in America. As per, World Health Organisation (WHO), 347 Mn people were suffering from diabetes globally in 2012, in which 11% population are having diabetic retinopathy. Increase in focus on Asia-pacific and LAMEA regions by various vendors ,is expected to boost growth of the market According to the World Bank, in 2015,10.4% of rate of prevalence of diabetes was observed in Brazil. Strategic acquisitions, geographic expansion, agreements, partnerships and new product launches are the most vital strategic implementations by most of the companies in the market of diabetic retinopathy. Need more information about this report @ https://www.precisionbusinessinsights.com/market-reports/global-diabetic-retinopathy-market/#ulp-14mlyhjMGhVjZqa3 ©2017 Precision BusinessInsights

  5. On the basis of regions, the global market of diabetic retinopathy has been segmented into five key regions, Latin America North America, Asia-Pacific, Europe, and Middle East & Africa. North America dominates the market followed by Asia-Pacific and Europe. The factors that are attributing for the market growth in North America are, people with high obesity rates are more prone to diabetes conditions. Large patient pool in European region with diabetic retinopathy is expected to drive the growth of the market. In emerging economies, due to the improvement in the healthcare infrastructure and rise in awareness in the people Owing to improved infrastructure and awareness among the people, improving on the quality of life (QALY) in diabetic patients, rise in demand of early detection and treatment of chronic conditions such as diabetic retinopathy are the factors that are driving the growth of the diabetic retinopathy market in Asia Pacific regions. Some of the players in diabetic retinopathy market are Abbott Laboratories (U.S.), Alimera Sciences (U.S.), Allergan plc (Ireland.), Ampio Pharmaceuticals. (U.S.), Bayer AG (Germany), F. Hoffmann-La Roche (Switzerland), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Regeneron Pharmaceuticals Inc. (U.S.), and Valeant (Canada). Get access to full summary @ https://www.precisionbusinessinsights.com/market-reports/global-diabetic-retinopathy-market/ ©2017 Precision BusinessInsights

  6. Precision Business Insights - About Us Precision Business Insights is one of the leading market research and business consulting firm that follow a holistic approach to solve problems of the clients. We adopt and implement new research methodologies to achieve better results, help our clients by providing actionable insights and strategies to make better business decisions. We provide consulting, syndicated and customized market research services based on our client needs. PBI’s mission is to provide high-quality market research reports and generate key insights to our clients. Our approachable strategies are help clients to make key decisions for business growth PBI caters consulting services to the market players in various domains such as Biotechnology, Pharmaceuticals, Medical Devices, Chemical, Electronics and Electrical, Veterinary, Agriculture, Food and Beverages. We provide impeccable research reports in quick turnaround time. Our logo represents what we do, Eagle in the logo represents the Precision as in the name of the company & its decision making skills and the hand shaking reflects the attitude of the team and how it work with its clients. Red represents passion, strength of the team and blue represents the depth of insights it gives to clients OurExpertise: • Market Intelligence • Growth Strategies • Competitive Benchmarking • Custom Market Research • Consulting Services • Company Profiles 6 ©2017 Precision BusinessInsights

  7. Research Methodology 7 ©2017 Precision BusinessInsights

  8. Research Methodology PBI 3 step Process Top DownApproach Primary Research 1st step –Collection of the relevantdata Secondary Research Paid and Free Databases 2nd step – Validating and quality checkof the data Supply and DemandSide Analysis 3rd step – Collection of the data and drawing insights from thedata Key Insights Bottom UpApproach 8 ©2017 Precision BusinessInsights

  9. EuropeOffice: Precision BusinessInsights, Kemp House, 152 – 160 City Road, London EC1V 2NX Toll Free : +1-866-598-1553 Email: sales@precisionbusinessinsights.com 9 ©2017 Precision BusinessInsights

More Related